We are live on ! Find out more
LCP

Lamond Capital Partners Portfolio holdings

AUM $14.3M
1-Year Est. Return 30.74%
This Fund
S&P 500
This Quarter Est. Return
-3.58%
1 Year Est. Return
-30.74%
3 Year Est. Return
+54.28%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.3M
AUM Growth
-$52.6M
Cap. Flow
-$51.9M
Cap. Flow %
-363.65%
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
1
Closed
6

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$18.3M
2
PBYI icon
Puma Biotechnology
PBYI
+$17.3M
3
AMGN icon
Amgen
AMGN
+$12.2M
4
ABBV icon
AbbVie
ABBV
+$2.79M
5
RXDX
Ignyta, Inc.
RXDX
+$626K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
1
AbbVie
ABBV
$450B
$14.3M 100%
250,000
-50,000
-17% -$2.79M
AMGN icon
2
Amgen
AMGN
$198B
– –
-75,000
Closed -$12.2M
ORCL icon
3
Oracle
ORCL
$364B
– –
-500,000
Closed -$18.3M
PBYI icon
4
Puma Biotechnology
PBYI
$434M
– –
-220,780
Closed -$17.3M
IMMU
5
DELISTED
Immunomedics Inc
IMMU
– –
-100,000
Closed -$307K
RXDX
6
DELISTED
Ignyta, Inc.
RXDX
– –
-46,721
Closed -$626K
ZLTQ
7
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-16,119
Closed -$460K

Similar funds

HCM
Hirzel Capital Management Dallas, Texas $15.1M AUM 5.29% 1-Year Est. Return
PPF
PartnerRe Principal Finance Greenwich, Connecticut $15.5M AUM 13.01% 1-Year Est. Return
PM
Platinum Management New York $16.4M AUM 30.38% 1-Year Est. Return
TSU
TD Securities (USA) New York $11M AUM 2.35% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
SCA
Strategic Capital Alternatives Gig Harbor, United States $6.3M AUM
GFWEV
G.F.W. Energy VII Irving, Texas $1.49M AUM 89.53% 1-Year Est. Return
STA
System Two Advisors Summit, New Jersey $23K AUM 23.64% 1-Year Est. Return

Lamond Capital Partners's Q1 2016 Portfolio in Review

As of Q1 2016, Lamond Capital Partners held 7 positions worth $14.3M, down 79% from $66.9M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Lamond Capital Partners withdrew a net $51.9M in Q1 2016, closing 6 positions and reducing 1 holding. Its most notable exit was Oracle, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 72% a quarter earlier, followed by Technology.

  • Lamond Capital Partners's biggest Q1 2016 reduction was AbbVie, cutting an estimated $2.79M.
  • Lamond Capital Partners fully exited Oracle in Q1 2016, selling an estimated $18.3M.
  • Lamond Capital Partners's ten largest holdings make up 100% of its $14.3M portfolio in Q1 2016.
  • Lamond Capital Partners opened 0 new positions and closed 6 in Q1 2016.
  • Lamond Capital Partners's portfolio value fell 79% quarter-over-quarter to $14.3M.

Based on Lamond Capital Partners's 13F filing for Q1 2016, filed 5 May 2016.